Markets snapped their five-session winning streak on Friday and ended lower amid a broad-based sell-off led by the IT pack. Technically, analysts say the Nifty witnessed profit-taking after encountering resistance near the 24,150 zone, which coincides with the 100-day EMA. While the broader recovery structure remains intact above the 23,700 support zone, the inability to sustain at higher levels suggests the possibility of a consolidation phase before the index resumes its gradual uptrend towards the 24,500–24,600 zone.

In today's trade, shares of Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGC among others will be in focus due to various news developments.

Home-grown FMCG firm Jyothy Labs, which is "cautiously optimistic" about growth in FY27, is expanding Exo into a broader dishwash franchise, as German consumer goods major Henkel AG & Co. KGaA exited its licensing arrangement for Pril and Fa brands in India.

Tata Motors has secured more than 3,400 orders for electric commercial vehicles (eCVs) across freight, logistics and passenger mobility segments, reflecting growing adoption of electric mobility among commercial fleet operators in India.

ONGC

State-run Oil and Natural Gas Corporation (ONGC) is repositioning itself as a more gas-focused energy producer, with Chairman and CEO Arun Kumar Singh saying the company should increasingly be viewed as a “gas and oil” firm rather than an “oil and gas” company.

Leading room air conditioner maker Voltas said it has crossed the milestone of selling one million units within the first three months of the ongoing 2026-27 financial year. The Tata Group company claimed it has achieved the landmark in record time and further strengthened its leadership position in the Indian room air conditioner (RAC) market.

Dalmia Bharat is planning to raise up to Rs 4,000 crore through various instruments to support its growth plans, as it targets to expand its manufacturing capacity to 110-130 million tonnes per annum by FY31 through a mix of acquisitions, greenfield and brownfield projects.

Sun Pharmaceutical Industries Ltd will acquire Mumbai-based Innovcare Lifesciences Private Ltd for about $28.7 million (around Rs 271.2 crore) in an all-cash deal, as India's largest drugmaker looks to strengthen its product portfolio.

Alembic Pharmaceuticals Ltd on Friday said it has received tentative approval from the US health regulator for its generic version of cancer treatment drug Binimetinib tablets.

Tech Mahindra has picked up nearly 4 lakh sq ft of office space in Hyderabad on a long-term lease, in one of the city’s largest office leasing transactions this year, highlighting continued demand for premium workspaces from technology occupiers.